Drug Discovery World

JULY 25, 2024

Over 5,000 genetic variants that enable certain cancers to thrive were identified, along with a potential therapeutic target to treat or even prevent these cancers from developing. The team also uncovered a link between certain disruptive BAP1 variants and higher levels of IGF-1, a hormone and growth factor.

Genetics 52

Genetics Research Drugs Gene 52

pharmaphorum

JULY 28, 2022

. “We are currently testing this hypothesis, with the goal of pursuing a development candidate targeting INHBE in the near future,” said Paul Nioi, head of Alnylam’s human genetics group. The post Alnylam finds belly fat gene and drug target in UK Biobank study appeared first on.

Biobanking 52

Biobanking Gene Gene Silencing Drugs 52

The Pharma Data

JANUARY 21, 2021

Four years ago, the University of Malta established a national ALS Registry and Biobank to identify ALS patients and collect data on their residence, occupation, lifestyle and environmental exposures. They are now working to identify what genetic aberrations are causing ALS in about half of the Maltese patients.

Research 52

Research DNA Hormones Vaccination 52